Viibryd and Methotrexate drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Viibryd (vilazodone hydrochloride) and Methotrexate (methotrexate sodium). Common drug interactions include peak expiratory flow rate decreased among females and pain among males.
The phase IV clinical study analyzes what interactions people have when they take Viibryd and Methotrexate. It is created by eHealthMe based on reports of 158 people who take the same drugs from the FDA, and is updated regularly.
What is Viibryd?
Viibryd has active ingredients of vilazodone hydrochloride. It is often used in depression. eHealthMe is studying from 11,106 Viibryd users. Check the latest studies of Viibryd.
What is Methotrexate?
Methotrexate has active ingredients of methotrexate sodium. It is often used in rheumatoid arthritis. eHealthMe is studying from 604,313 Methotrexate users. Check the latest studies of Methotrexate.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
158 people who take Viibryd and Methotrexate together, and have interactions are studied.
What are the common drug interactions of Viibryd and Methotrexate, by gender? *
What are the common drug interactions of Viibryd and Methotrexate, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Viibryd and Methotrexate?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Viibryd (11,106 reports)
- Methotrexate (604,313 reports)
Browse all drug interactions of Viibryd and Methotrexate:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Viibryd:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Methotrexate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Viibryd and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Methotrexate and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Henien M, Carey B, Hullah E, Sproat C, Patel V, "methotrexate-associated osteonecrosis of the jaw: A report of two cases", Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2017 Dec .
- Henien M, Carey B, Hullah E, Sproat C, Patel V, "methotrexate-associated osteonecrosis of the jaw: A report of two cases", Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2017 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on vilazodone hydrochloride and methotrexate sodium (the active ingredients of Viibryd and Methotrexate, respectively), and Viibryd and Methotrexate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Bloody Discharge and drugs of ingredients of fluticasone propionate - now
- Nasal Discharge and drugs of ingredients of amoxicillin - 2 seconds ago
- Intervertebral Disc Injury and drugs of ingredients of clonidine - 2 seconds ago
- Could Hydroxychloroquine Sulfate cause Hyperhidrosis? - 4 seconds ago
- Renal Impairment and drugs of ingredients of folic acid - 5 seconds ago
- Blister and drugs of ingredients of pantothenic acid (vitamin b5) - 6 seconds ago
- Foetal Heart Rate Disorder and drugs of ingredients of misoprostol - 9 seconds ago
- Could Xolair cause Lymphocyte Count Decreased? - 9 seconds ago
- Glucose Tolerance Impaired and drugs of ingredients of secukinumab - 14 seconds ago
- Tendonitis and drugs of ingredients of terbinafine hydrochloride - 15 seconds ago